Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Many patients with cervical cancer are often young and underserved ... “If you're going to ask the immune system to behave in the way that you would ...
... themselves from T cells—the immune system's front-line anti-cancer weapon—by producing high levels of beta-catenin, an intracellular messenger.
New drug to bring Scots blood cancer patients hope ... and increased risk of cancerbecause they suppress the body's entire immune system.
The objective of HyperAcute immunotherapies is to elicit an antitumor response by "educating" the immune system to attack a patient's own cancer ...
“This year* marks a turning point in cancer, as long-sought efforts to unleash theimmune system against tumors are paying off—even if the future ...
Though molecularly targeted drugs are not yet available for most cancer ... The newest innovations, which activate the immune system, work even ...
... an indication that the body's immune system might be able to be trained to ... This process worked on cancerous mice, allowing them to live cancer-free for ... to the mice have already been used in clinical trials for cancer patients.
'Cancer stem cells', as they were termed more than a century later, ..... The use of mice that harbor a human immune system (humanized mice) may ..
Today, we're investing more than ever in our effort to bring innovative treatment options that help a person's own immune system fight cancer.
"This is the first identified cell-intrinsic cancer-causing pathway that disrupts T cell infiltration in melanoma," said study author Thomas Gajewski, MD, ...
The Cancer Immunotherapy Trials Network (CITN) and NanoString Technologies, Inc. have recently announced they will collaborate to find ...
The objective of HyperAcute immunotherapies is to elicit an antitumor response by "educating" the immune system to attack a patient's own cancer ...
Heat Biologics, Inc. ("Heat Biologics", "Heat" or the "Company") HTBX, -4.18% a clinical stage cancer immunotherapy company, announced today that ...
CORRECTING and REPLACING -- Heat Biologics Announces Initiation of Phase 1b Trial of ... -GlobeNewswire (press release)
These data demonstrate the strength of Roche's oncology pipeline, particularly in cancer immunotherapy and personalised medicine.
Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO - Business Wire (press release)
Pivotal data for Roche medicines in lung and blood cancers to be presented at ASCO 2015 - European Pharmaceutical Review
Here they are, all free access:
Surgery and Medical Tx Offer Similar Survival for Laryngeal CA
But larynx preservation protocol can improve voice function
Young-adult survivors express problems and concerns, but get little professional guidance. Read more
Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer (PC), is a highly aggressive malignancy of the exocrine ...
... inhibitors for multiple Ras mutants: Some of the peptides kill lung cancer cells with either of two different Ras mutations, some kill pancreatic cancer ..
The high death rate from cancer is mainly due to metastasis and relapse ... types of cancer, such as breast cancer, gastric cancer, pancreatic cancer, ...
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies - Nature.com
Our aim is to investigate the risk association between allopurinol use and cancer incidence among gout patients using clinical evidence.
Previous studies have linked moderate coffee consumption with a reduced risk of oral cancer, bladder cancer, colon cancer and oesophageal cancer, ...
This paper aims to review the most important mechanisms in bladder cancer tumorigenesis and describe the new therapeutic options currently ...
The problem with this explanation is that half the 722 pancreatic cancer patients enrolled in NewLink's study aren't being treated with HyperAcute ...
FRANKFURT – Germany's Merck KGaA said that experimental cancer drug evofosfamide, which it is jointly developing with Threshold ...
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the ... - PR Newswire (press release)
The report was recently published in the Journal of Steroid Biochemistry and Molecular Biology and stated that pancreatic cancer rates are highest in ...
Furthermore, epidermal growth factor plays an important role in many other cancers, like prostate, breast, colon, and pancreatic cancer. “All those ..
"Wouldn't it be amazing if we could actually do a blood test and then determine if someone has pancreatic or ovarian cancer early, at a time when we ...
Pancreatic cancer is the fifth leading cause of cancer death in Western societies, with a five year survival rate of less than 5%. The treatment and ...
- Melanoma Vaccine May Be Approved By October
A new cancer immunotherapy may get the green light this fall.
Did you know? May is skin cancer awareness month. Stay up to date with our full skin cancer coverage.
- Researchers Discover Breast Cancer Susceptibility Gene
An important moment in personalized treatment occurred recently as researchers in Canada discovered a new gene mutation called RecQ helicase-like (RECQL).
Also: The five year survival rate of breast cancer is over 90% when caught early. Be sure to check out our breast cancer coverage and increase the odds of early detection in patients.
- Regular Aspirin Use Could Up Colorectal Cancer Risk in Some
It has often been thought that regular use of aspirin can lower colorectal cancer risk, but recent research has shown that this may not be the case for all.
Finally: For even more on colorectal and other types of gastrointestinal cancer – we've got you covered.
Science Daily Cancer News
Men with naturally high levels of the female hormone estrogen may have a greater risk of developing breast cancer, according to research by an international collaboration. This is the first time a link between estrogen levels in the blood and male breast cancer has been identified, despite its connection to breast, womb and ovarian cancers in women.
Researchers have identified three genes that play a pivotal role in the brain tumor choroid plexus carcinoma, a discovery that lays the groundwork for more effective treatment of this rare, often fatal cancer.
The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus. The study also found the 9-Valent vaccine, under the trademark of Gardasil-9, has the potential to protect against an additional 8 percent of oropharyngeal cancers, which include the base of the tongue and tonsils. This disease is the second-most-common HPV-associated cancer.
The proportion of parents who delay having children until age 35 or older continues to increase, but the long-term health consequences for these children are still emerging. A father's age at his infant's birth is linked to the risk that his child will develop blood and immune system cancers as an adult, particularly for only children, a new study concludes.
Imagine having a complete catalog of the best drug targets to hit in a deadly form of cancer. Imagine having a master catalog of such targets for all major cancers. Scientists have now published a method of doing precisely this, using the revolutionary gene-editing technology called CRISPR.
Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth.
A faster, more accurate method to assess cancer risk from certain common environmental pollutants has been developed by scientists. The study focused on an important class of pollutants known as polycyclic aromatic hydrocarbons, or PAHs, that commonly occur in the environment as mixtures such as diesel exhaust and cigarette smoke.
Key steps in cell division have now been revealed by new research, possibly leading to treatments aimed at inhibiting cancer cell division, scientists report.
Sym004, a mixture of two anti-epidermal growth factor receptor (EGFR) antibodies, was found to be clinically active in patients with advanced colorectal cancer that had become resistant to prior anti-EGFR therapies.
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth, scientists say. The findings may help identify cancer survivors who are most likely to become obese, and could provide a foundation for future research efforts aimed at characterizing molecular pathways involved in the link between childhood cancer treatment and obesity.
Swollen lymph nodes are often the earliest sign of metastatic spread of cancer cells. Now cancer researchers and immunologists have discovered how cancer cells can infiltrate the lymphatic system by ‘disguising’ themselves as immune cells (white blood cells). The researchers hope that this finding will inform the development of new drugs.
Researchers combined finely crafted nanoparticles with one of nature's potent disrupters to prevent the spread of triple-negative breast cancer in mouse models. The researchers are working toward clinical trials and exploring use of the technology for other cancers and diseases.
Roughly 1 in 4 women having breast conserving surgery (BCS) return to the surgical suite for further resection because of cancerous tissue left behind due to unclear margins. A research team focuses on coming up with a practical solution that both preserves the surgical practice of inking the margins of breast cancer tumors, and allows quality imaging post-inking.
Ten-year survival of a rare malignancy called mesenchymal chondrosarcoma has been reported to be as low as 20 percent. But a new study has found survival is not as dismal as prior reports. More than half (51 percent) of patients survived at least five years, and 43 percent survived at least 10 years.
Researchers recently conducted a study that found low-income and uninsured women in states that are not expanding their Affordable Care Act (ACA) Medicaid coverage are less likely to receive breast and cervical cancer screenings compared to states that are implementing expansions.
Significant advances have been made with regard to the development of individualized immunotherapy strategies for treating cancer. They have managed to identify the relevant genetic changes or mutations associated with various types of cancer and have determined their individual blueprints. This makes it possible for the scientists to readily produce customized cancer vaccines of the kind that have already been demonstrated to be effective in animal models.
Researchers have developed and tested a new tool that searches for the most common genetic anomalies seen in cancer. The assay demonstrates the ability to make gene sequencing easier over a large volume of samples.
Magnetic resonance imaging (MRI) provides important information about a woman's future risk of developing breast cancer, according to a new study. Researchers said the findings support an expanded role for MRI in more personalized approaches to breast cancer screening and prevention.
Cancer is more likely to develop in people who are very overweight (obese), because surplus body fat interferes with various hormone cycles and with glucose and fat metabolism. A metabolic expert draws attention to the fact that more and more people are suffering from obesity, spurring several studies to investigate the links between obesity, metabolic disorders and cancer.
Tambahkan Komentar